Sinotherapeutics Inc. A (688247) — Cash Flow Reinvestment Rate
Sinotherapeutics Inc. A (688247) has a Cash Flow Reinvestment Rate of 2.10x as of December 2025, reinvesting CN¥200.10 Million (capex CN¥41.56 Million plus investments CN¥158.54 Million) from operating cash flow of CN¥95.33 Million. See Sinotherapeutics Inc. A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinotherapeutics Inc. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Sinotherapeutics Inc. A across 6 annual periods. For the full cash flow conversion analysis, see Sinotherapeutics Inc. A (688247) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Sinotherapeutics Inc. A (2020–2025)
Year-by-year capital reinvestment analysis for Sinotherapeutics Inc. A. See Sinotherapeutics Inc. A leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.10x | CN¥200.10 Million | CN¥95.33 Million | CN¥41.56 Million | ▼ -43.5% |
| 2024 | 3.72x | CN¥483.84 Million | CN¥130.23 Million | CN¥94.93 Million | ▼ -55.2% |
| 2023 | 8.30x | CN¥107.57 Million | CN¥12.96 Million | CN¥38.96 Million | ▲ +61.3% |
| 2022 | 5.15x | CN¥376.64 Million | CN¥73.18 Million | CN¥176.34 Million | ▲ +835.0% |
| 2021 | 0.55x | CN¥80.24 Million | CN¥145.77 Million | CN¥16.01 Million | ▲ +80.0% |
| 2020 | 0.31x | CN¥64.23 Million | CN¥210.04 Million | CN¥38.34 Million | — |